By Ben James ( September 3, 2010, 2:25 PM EDT) -- Ranbaxy Laboratories Ltd. has admitted that its proposed generic version of the antiviral drug Valcyte would infringe a patent asserted by Roche Palo Alto LLC and plans to launch its generic product no later than March 2013, pursuant to a settlement that resolves litigation Roche brought against Ranbaxy in 2006....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.